Published in AIDS Weekly, December 16th, 2002
Phil Radlick, PhD, has resigned as president and CEO and as a director of the company. He will continue on as a consultant to the company.
In addition, chairman Richard G. Babbitt and board members S. Lewis Meyer, PhD, and Frank M. Placenti have been appointed to a newly created executive committee of the board of directors. Former chairman Christopher A. Marlett also has resigned as a director of the company. The board of directors has commenced a search for new director candidates.
The company has retained an executive search...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.